Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

<p>Abstract</p> <p>Background</p> <p>Intravenous recombinant tissue plasminogen activator (rtPA) is approved in Europe for use in patients with acute ischaemic stroke who meet strictly defined criteria. IST-3 sought to improve the external validity and precision of the...

Full description

Bibliographic Details
Main Authors: Sandercock Peter, Lindley Richard, Wardlaw Joanna, Dennis Martin, Innes Karen, Cohen Geoff, Whiteley Will, Perry David, Soosay Vera, Buchanan David, Venables Graham, Czlonkowska Anna, Kobayashi Adam, Berge Eivind, Slot Karsten, Murray Veronica, Peeters Andre, Hankey Graeme J, Matz Karl, Brainin Michael, Ricci Stefano, Cantisani Teresa A, Gubitz Gordon, Phillips Stephen J, Antonio Arauz, Correia Manuel, Lyrer Phillippe, Kane Ingrid, Lundstrom Erik
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/12/1/252

Internet

http://www.trialsjournal.com/content/12/1/252

Similar Items